EMA recommends European approval for Zealands Pharma pen out-licensed to Novo Nordisk
Zealand Pharma has received a thumbs up for Zegalogue from a panel of experts at the European Medicines Agency (EMA).
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Zealand Pharma CEO: "We've never been stronger"
For subscribers
Zealand Pharma submits dasiglucagon for review in the US
For subscribers